FDA approves Pfizer's Hemophilia B Gene Therapy, Beqvez : co

Pfizer's groundbreaking $3.5 million gene therapy for hemophilia B just got FDA approval. Here’s what it means for patients and the future of medicine

Related Keywords

North Carolina , United States , Adam Cuker , Qure Hemgenix , Drug Administration , Pfizer , Hemophilia Thrombosis Program , Penn Comprehensive , Spark Therapeutics , Bio Developments , Cell Amp Gene Therapies , Hemophilia , Gene Therapy , Adeno Associated Virus ,